Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Background Debate exists as to whether the higher hemoglobin A1c (HbA1c) levels observed in black persons than in white persons are due to worse glycemic control or racial differences in the glycation of hemoglobin. Objective To determine whether a racial difference exists in the relationship of mean glucose and HbA1c. Design Prospective, 12-week observational study. Setting 10 diabetes centers in the United States. Participants 104 black persons and 104 white persons aged 8 years or older who had had type 1 diabetes for at least 2 years and had an HbA1c level of 6.0% to 12.0%. Measurements Mean glucose concentration, measured by using continuous glucose monitoring and compared by race with HbA1c, glycated albumin, and fructosamine values. Results The mean HbA1c level was 9.1% in black persons and 8.3% in white persons. For a given HbA1c level, the mean glucose concentration was significantly lower in black persons than in white persons (P = 0.013), which was reflected in mean HbA1c values in black persons being 0.4 percentage points (95% CI, 0.2 to 0.6 percentage points) higher than those in white persons for a given mean glucose concentration. In contrast, no significant racial differences were found in the relationship of glycated albumin and fructosamine levels with the mean glucose concentration (P > 0.20 for both comparisons). Limitation There were too few participants with HbA1c levels less than 6.5% to generalize the results to such individuals. Conclusion On average,…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A1C levels may be 0.4% to 0.6% higher in Blacks and Hispanics compared with Whites, despite equivalent levels of hyperglycemia in those with T2D.11-17”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [17]
In the citing paper
“At the same average glucose values, HbA 1c was approximately 0.4% higher in the former compared with the latter.”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [342]
In the citing paper
“A study in type 1 diabetes demonstrated a difference in the relationship between mean average glucose measured with CGM and HbA 1c in Black compared with White participants (342).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [342]
In the citing paper
“As discussed in section 2, “Diagnosis and Classification of Diabetes,” there is controversy regarding the clinical significance of differences in A1C by self-reported race and ethnicity (9)(10)(11)(12).”
From 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. (2026) · cites this paper as [9]
In the citing paper
“Studies have found that African American individuals have slightly higher A1C levels than non-Hispanic White or Hispanic people (22 -25).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [22]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Translating the A1C assay into estimated average glucose values
Nathan, D. M., Kuenen, J., Borg, R., Zheng, H., Schoenfeld, D., Heine, R. J., & for the A1c-Derived Average Glucose (ADAG) Study Group (2008) · Diabetes Care · doi:10.2337/dc08-0545 · Cited by 1,812
Self-citationContinuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities
Rodbard, D. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0417 · Cited by 737 · cited 1×
“Food and Drug Administration approval after the study (25, 26).”
BackgroundThe Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System
Bailey, T., Bode, B. W., Christiansen, M. P., Klaff, L. J., & Alva, S. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0378 · Cited by 685 · cited 2×
“Food and Drug Administration approval after the study (25, 26).”
BackgroundMethodHerman, W. H., Ma, Y., Uwaifo, G., Haffner, S., Kahn, S. E., Horton, E. S., Lachin, J. M., Montez, M. G., Brenneman, T., Barrett-Connor, E., et al. (2007) · Diabetes Care · doi:10.2337/dc06-2003 · Cited by 574
Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c
Cohen, R. M., Franco, R. S., Khera, P. K., Smith, E. P., Lindsell, C. J., Ciraolo, P. J., Palascak, M. B., & Joiner, C. H. (2008) · Blood · doi:10.1182/blood-2008-04-154112 · Cited by 478 · cited 2×
“8) Age, n (%) 8 to <13 y 17 (14) 21 (20) 13 to <18 y 24 (19) 31 (29) 18 to <30 y 20 (16) 12 (11) 30 to <50 y 39 (31) 22 (21) ≥50 y 25 (20) 21 (20) Female, n (%) 62 (60) 55 (53) Annual household income, n (%) <$50 000 44 (59) 18 (23) $50 000 to <$100 000 24 (32) 23 (30) ≥$100 000 7 (9) 36 (47) Mean duration of diabetes…”
BackgroundThe fallacy of average: how using HbA1c alone to assess glycemic control can be misleading
Beck, R. W., Connor, C. G., Mullen, D. M., Wesley, D. M., & Bergenstal, R. M. (2017) · Diabetes Care · doi:10.2337/dc17-0636 · Cited by 477
Self-citationA1c versus glucose testing: a comparison
Sacks, D. B. (2011) · Diabetes Care · doi:10.2337/dc10-1546 · Cited by 461 · cited 2×
“8) Age, n (%) 8 to <13 y 17 (14) 21 (20) 13 to <18 y 24 (19) 31 (29) 18 to <30 y 20 (16) 12 (11) 30 to <50 y 39 (31) 22 (21) ≥50 y 25 (20) 21 (20) Female, n (%) 62 (60) 55 (53) Annual household income, n (%) <$50 000 44 (59) 18 (23) $50 000 to <$100 000 24 (32) 23 (30) ≥$100 000 7 (9) 36 (47) Mean duration of diabetes…”
BackgroundGlycemic control in youth with diabetes: the SEARCH for Diabetes in Youth Study
Petitti, D. B., Klingensmith, G. J., Bell, R. A., Andrews, J. S., Dabelea, D., Imperatore, G., Marcovina, S., Pihoker, C., Standiford, D., Waitzfelder, B., et al. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.05.025 · Cited by 397
Self-citationTahara, Y., & Shima, K. (1995) · Diabetes Care · doi:10.2337/diacare.18.4.440 · Cited by 380 · cited 3×
“Similar analyses to those described above were conducted for fructosamine and glycated albumin, using a maximum of 42 and 53 days of prior CGM data, respectively (28).”
MethodInfluentialRacial-ethnic disparities in management and outcomes among children with type 1 diabetes
Willi, S. M., Miller, K. M., DiMeglio, L. A., Klingensmith, G. J., Simmons, J. H., Tamborlane, W. V., Nadeau, K. J., Kittelsrud, J. M., Huckfeldt, P., Beck, R. W., et al. (2015) · Pediatrics · doi:10.1542/peds.2014-1774 · Cited by 367
Self-citation
Research works printed but not linked: 1
- Boltri JM, 2005, Ethn Dis, 15, 562
Cited by
Items 101–200 of 318
Kazemi, M., Kim, J. Y., Parry, S. A., Azziz, R., & Lujan, M. E. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.12.019 · Cited by 32
Yauch, L. M., Velazquez, E. P., Piloya, T., Mungai, L., Omar, A. A., & Moran, A. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.135 · Cited by 28
“9 mmol/L) 29 ± 29 [27;51] 36 ± 27 [36;19] 39 ± 34 [39;34] 23 ± 30 [0;43]”
Walker, A. F., Hu, H. Z., Cuttriss, N., ANEZ-ZABALA, C., Yabut, K., Haller, M. J., & Maahs, D. M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa462 · Cited by 29
Brown, S. A., Basu, A., & Kovatchev, B. P. (2019) · Diabetic Medicine · doi:10.1111/dme.13944 · Cited by 27
Ford, C. N., Leet, R. W., Kipling, L. M., Rhee, M. K., Jackson, S. L., Wilson, P. W. F., Phillips, L. S., & Staimez, L. R. (2019) · Diabetic Medicine · doi:10.1111/dme.13979 · Cited by 31
Prevalence of diabetic retinopathy in children and adolescents at an urban tertiary eye care center
Porter, M., Channa, R., Wagner, J., Prichett, L. M., Liu, T. Y. A., & Wolf, R. M. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13037 · Cited by 30
“We noted significantly higher HbA1c values in black and Hispanic patients when compared with white patients, which has also been noted in previous studies.(36,37) Racial disparities in glycemic control and diabetes management have been previously reported.”
BackgroundResultMiller, R. G., Mychaleckyj, J. C., Önengüt-Gümüşcü, S., Orchard, T. J., & Costacou, T. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-003068 · Cited by 30
“47 Thus, our results may not apply to more diverse populations, and more research in non-white populations is critically needed.”
Howe, C. J., Morone, J. F., Hawkes, C. P., & Lipman, T. H. (2023) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106221145323 · Cited by 28
Cheng, W., Huang, R., Pu, Y., Li, T., Bao, X., Chen, J., Li, G., Wu, H., & Wei, Z. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2330615 · Cited by 27
“…age, genetic variation, red blood cell lifespan, iron deficiency, and anaemia, contribute to the mismatch between hba1c and blood glucose levels [9–13]. therefore, the haemoglobin glycation index (hGi) was first proposed by hempe et al. in 2002 to quantify individual differences in hba1c levels.”
BackgroundYouth prediabetes and type 2 diabetes: Risk factors and prevalence of dysglycaemia
Saleh, M. W., Kim, J. Y., March, C. A., Gebara, N. Y., & Arslanian, S. A. (2021) · Pediatric Obesity · doi:10.1111/ijpo.12841 · Cited by 26
Diaz-Thomas, A., Golden, S. H., Dabelea, D., Grimberg, A., Magge, S. N., Safer, J. D., Shumer, D. E., & Stanford, F. C. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad124 · Cited by 29
Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels
Garg, R. (2018) · Annals of Internal Medicine · doi:10.7326/l17-0588 · Cited by 26
LeBlanc, E. S., Pratley, R. E., Dawson-Hughes, B. F., Staten, M. A., Sheehan, P., Lewis, M. R., Peters, A. L., Kim, S. H., Chatterjee, R., Aroda, V. R., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0240 · Cited by 27
Restrepo, B. I., Kleynhans, L., Salinas, A. B., Abdelbary, B. E., Tshivhula, H., Aguillón-Durán, G. P., Kunsevi-Kilola, C., Salinas, G., Stanley, K., Malherbe, S. T., et al. (2018) · Tuberculosis · doi:10.1016/j.tube.2018.08.007 · Cited by 26
Diabetes technology in people with diabetes and advanced chronic kidney disease
Galindo, R. J., Soliman, D., Cherñavvsky, D. R., & Rhee, C. M. (2024) · Diabetologia · doi:10.1007/s00125-024-06244-y · Cited by 25
Challenges to hemoglobin A1c as a therapeutic target for type 2 diabetes mellitus
Ikeda, M., & Shimazawa, R. (2019) · Journal of General and Family Medicine · doi:10.1002/jgf2.244 · Cited by 28
Xu, Y., Bergenstal, R. M., Dunn, T. C., Ram, Y., & Ajjan, R. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14763 · Cited by 23
“Results: The mean age (range) was 30 years (8-72) with 94 younger than 19 years,”
BackgroundSelf-citationShahim, B., Gyberg, V., Bacquer, D. D., Kotseva, K., Backer, G. D., Schnell, O., Tuomilehto, J. O., Wood, D., & Rydén, L. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0665-4 · Cited by 26
“Markers of dysglycaemia may vary by race and ethnicity [49, 50].”
BackgroundLi, J., Li, Y., Ma, W., Liu, Y., Yin, X., Xie, C., Bai, J., & Zhang, M. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.09.028 · Cited by 23
Rasouli, N., Younes, N., Utzschneider, K. M., Inzucchi, S. E., Balasubramanyam, A., Cherrington, A., Ismail‐Beigi, F., Cohen, R. M., Olson, D. E., DeFronzo, R. A., et al. (2020) · Diabetes Care · doi:10.2337/dc20-1787 · Cited by 22
Self-citationGAL, J., Li, Z., Willi, S. M., & Riddell, M. C. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13391 · Cited by 27
“The association between mean active MET-minutes per day and mean glucose, glucose coefficient of variation, TIR, TAR (>180, >250 mg/dl), and TBR ( 70, 54 mg/dl) was assessed using a linear regression model adjusted for age, gender, and baseline HbA1c.”
BackgroundSelf-citationFranck, M., Daunizeau, C., Aronoff, J. E., Tanner, K., Trumble, B. C., Franceschi, C., Hertel, J., Fülöp, T., Lemoine, M., Gurven, M., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102880 · Cited by 25
Health Disparities Likely Emerge Early in the Course of Type-1 Diabetes in Youth
Tremblay, E. S., Liu, E., & Laffel, L. M. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221082646 · Cited by 21
Racial and Ethnic Differences in the Association Between Mean Glucose and Hemoglobin A1c
Karter, A. J., Parker, M. M., Moffet, H. H., & Gilliam, L. K. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0153 · Cited by 24
“12 Perhaps treat-ment decisions should be based on direct glucose measurements rather than A1C thresholds.”
InfluentialAngellotti, E., Muppavarapu, S., Siegel, R. D., & Pittas, A. G. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0405 · Cited by 21
“9 6 There are many potential reasons that can explain why GMI LI differed from GMI P in our study.”
Association of time in range with postoperative wound healing in patients with diabetic foot ulcers
Huang, Z., Zhang, H., Huang, Y., Ye, S.-L., Ma, Y., Xin, Y., Chen, X., & Zhao, S. (2021) · International Wound Journal · doi:10.1111/iwj.13725 · Cited by 21
“0 mmol/L.(16) TIR reflects hypoglycaemia events and blood glucose fluctuations that can provide guidance for glycaemic control.”
BackgroundStaimez, L. R., Kipling, L. M., Ham, J. N., Legvold, B. T., Jackson, S. L., Wilson, P. W. F., Rhee, M. K., & Phillips, L. S. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109935 · Cited by 22
Ram, Y., Xu, Y., Cheng, A., Dunn, T. C., & Ajjan, R. (2024) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2023-003470 · Cited by 21
Seo, J. Y., Hwang, S.-S., Kim, J. H., Lee, Y. A., Lee, S. Y., Shin, C. H., & Yang, S. W. (2018) · Scientific Reports · doi:10.1038/s41598-018-20274-8 · Cited by 20
Self-citationAndrisse, S., Garcia‐Reyes, Y., Pyle, L. L., Kelsey, M. M., Nadeau, K. J., & Cree‐Green, M. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab008 · Cited by 21
Domanski, P., Ray, A., Lafata, K. J., Firouzi, F., Chakrabarty, K., & Pflüger, D. (2024) · Journal of Applied Biomedicine · doi:10.1016/j.bbe.2024.07.006 · Cited by 20
Hemoglobin A1c and Type 2 Diabetes Incidence Among Adolescents With Overweight and Obesity
Hoe, F. M., Darbinian, J. A., Greenspan, L. C., & Lo, J. C.-M. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.51322 · Cited by 20
Isaksson, S. S., Imberg, H., Hirsch, I. B., Schwarcz, E., Hellman, J., Wijkman, M. O., Bolinder, J., Nyström, T., Holmer, H., Hallström, S., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06151-2 · Cited by 21
“Although race may influence the association of MG and TIR with HbA 1c [29, 30], it was not a factor in the current study, in which all participants were white.”
Estimating HbA1c from timed Self-Monitored Blood Glucose values
Fan, W., Zheng, H., Wei, N., & Nathan, D. M. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.04.023 · Cited by 19
Gavin, J. R., & Bailey, C. J. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0057 · Cited by 18
Haemoglobin A1c or Glycated Albumin for Diagnosis and Monitoring Diabetes: An African Perspective
George, J. A., & Erasmus, R. T. (2018) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-018-0755-9 · Cited by 19
Kelsey, M. M., Zeitler, P. S., Drews, K. L., & Chan, C. L. (2019) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2019.07.031 · Cited by 18
Hemoglobin A1c Patterns of Youth With Type 1 Diabetes 10 Years Post Diagnosis From 3 Continents
Sherr, J. L., Schwandt, A., Phelan, H., Clements, M. A., Holl, R. W., Benitez‐Aguirre, P., Miller, K. M., Woelfle, J., Dover, T., Maahs, D. M., et al. (2021) · PEDIATRICS · doi:10.1542/peds.2020-048942 · Cited by 20
Ismail, H. M., Spall, M., Evans‐Molina, C., & DiMeglio, L. A. (2023) · Pilot and Feasibility Studies · doi:10.1186/s40814-023-01373-4 · Cited by 18
Self-citationTillmann, F.-P., Schmitz, M., Rump, L. C., & Quack, I. (2017) · International Urology and Nephrology · doi:10.1007/s11255-017-1754-0 · Cited by 19
When Clinical Practice Guidelines Collide: Finding a Way Forward
Greenfield, S., & Kaplan, S. H. (2017) · Annals of Internal Medicine · doi:10.7326/m17-2665 · Cited by 18
Wang, J., Zhang, L., Bai, Y., Wang, X., Wang, W., Li, J., & Zhou, S. (2022) · Journal of Diabetes · doi:10.1111/1753-0407.13345 · Cited by 19
Ekhlaspour, L., Tabatabai, I., & Buckingham, B. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819851790 · Cited by 17
Puberty Is Associated with a Rising Hemoglobin A1c, Even in Youth with Normal Weight
Kelsey, M. M., Severn, C., Hilkin, A. M., Pyle, L., Nadeau, K. J., & Zeitler, P. S. (2020) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2020.10.044 · Cited by 17
Skinner, S. C., Diaw, M., Mbaye, M. N., Joly, P., Renoux, C., Masson, C., Cuerq, C., Lopez, P., Ndour, E. H. M., Diédhiou, D., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212552 · Cited by 18
Selvin, E., & Sacks, D. B. (2017) · Annals of Internal Medicine · doi:10.7326/m17-1231 · Cited by 17
Kaushal, T., TINSLEY, L. J., Volkening, L. K., Turcotte, C., & Laffel, L. M. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac476 · Cited by 16
Galindo, R. J., Moazzami, B., Tuttle, K. R., Bergenstal, R. M., Peng, L., & Umpierrez, G. E. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0145 · Cited by 17
“5,25 Our sample consisted of > 80% of African American participants, in whom HbA1c may be 0.4% – 0.5% higher compared with a white reference group with comparable glycemia.”
InfluentialSelf-citationAbdulhameed, Y. A., McClintock, P. V. E., & Stefanovska, A. (2020) · Journal of Biophotonics · doi:10.1002/jbio.201960131 · Cited by 16
Holt, R. I. G., DeVries, J. H., Fischl, A. H., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, É., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05600-6 · Cited by 19
Self-citationNathan, D. M., Herman, W. H., Larkin, M., Krause-Steinrauf, H. J., Assi, H. A., Ahmann, A., Brown-Friday, J., Hsia, D. S., Harindhanavudhi, T., Johnson, M. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-1362 · Cited by 17
Rodríguez, J., Camiña, F., Devesa, J. B. O., Rodríguez‐Segade, S., & Rodríguez, Á. (2025) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2025-0011 · Cited by 16
“Additionally, test results may be in fl uenced by ethnic di ff erences in glycosylation rates and during pregnancy [17 – 20].”
Chalew, S. A., Kamps, J. L., Jurgen, B., Gómez, R., & Hempe, J. M. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.107519 · Cited by 16
Xu, Y., Hirota, Y., Ajjan, R., Yamamoto, A., Matsuoka, A., Ogawa, W., & Dunn, T. C. (2021) · Diabetes and Vascular Disease Research · doi:10.1177/14791641211013734 · Cited by 15
Improved individual and population-level HbA1c estimation using CGM data and patient characteristics
Grossman, J., Ward, A., Crandell, J., Prahalad, P., Maahs, D. M., & Scheinker, D. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.107950 · Cited by 15
One Size Fits All Versus Individualized Medicine in Type 1 Diabetes Management
Midyett, L. K. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0109 · Cited by 18
HbA1c and Diabetes: Mismatches and Misclassifications
Rhee, M. K. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa185 · Cited by 15
Narasaki, Y., Park, E., You, A. S., Daza, A. C., Peralta, R. A., Guerrero, Y., Novoa, A., Amin, A., Nguyen, D. V., Price, D. A., et al. (2021) · Seminars in Dialysis · doi:10.1111/sdi.13009 · Cited by 15
“Furthermore, there are racial differences in glycation, such that HbA1c levels tend to overestimate mean glucose concentrations in Black persons compared with White persons.(25) In addition, as HbA1c provides an average of long-term glycemic status, it may not convey information”
BackgroundToschi, E., Michals, A. L., Adam, A., DAVIS, D. J., Atakov-Castillo, A., Slyne, C., & Munshi, M. N. (2021) · Diabetes Care · doi:10.2337/dc21-1373 · Cited by 14
Making sense of glucose sensors in end-stage kidney disease: A review
Williams, M. E., Steenkamp, D., & Wolpert, H. A. (2022) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2022.1025328 · Cited by 14
Sellers, S. L., Cunningham, B. A., & Bonham, V. L. (2018) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-018-0505-y · Cited by 14
Racial Disparities in Pediatric Type 1 Diabetes: Yet Another Consequence of Structural Racism
Hawkes, C. P., & Lipman, T. H. (2021) · PEDIATRICS · doi:10.1542/peds.2021-050333 · Cited by 14
Beck, R. W., Miller, K. M., & Foster, N. C. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0129 · Cited by 15
Self-citationStimson, R. H., Dover, A. R., Forbes, S., Strachan, M. W. J., McKnight, J. A., & Gibb, F. W. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820967335 · Cited by 13
Walker, A. F., Haller, M. J., Addala, A., Filipp, S. L., Lal, R., Gurka, M. J., Figg, L. E., Hechavarria, M., Zaharieva, D. P., Malden, K. G., et al. (2024) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2024-004229 · Cited by 13
“While some studies have identified differences in HbA1c between NHB and NHW individuals with similar glycemia, 42 this does not explain the full difference as demonstrated in other research that includes consideration of systemic inequities for NHB communities.”
Takeuchi, M., & Kawakami, K. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7120539 · Cited by 13
“For example, among persons with type 1 diabetes, the overestimation of HbA1c levels could occur in black persons compared with white persons, possibly because of racial differences in the hemoglobin glycation [22].”
BackgroundThe investigation of diabetes in people living with HIV: A systematic review
Daultrey, H. E., Yousseff, E., Wright, J. E., Davies, K. A., Chakera, A. J., & Levett, T. J. (2020) · Diabetic Medicine · doi:10.1111/dme.14454 · Cited by 13
“It is not possible to explain the high incident rates, only four studies measured incidence and all based in different countries, using different diagnostic methods, with a wide range in population sizes (39-7177).”
MethodResultHarris, N., Weaver, K. D., Beal, S. G., & Winter, W. E. (2020) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfaa202 · Cited by 13
Chalew, S. A., & Hamdan, M. A. A. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12696 · Cited by 13
Hussein, Y. H. H., & Soliman, A.-Z. M. (2022) · Journal of Family and Community Medicine · doi:10.4103/jfcm.jfcm_114_22 · Cited by 12
“4% was considered good glycemic control.[16]”
Utilizing the New Glucometrics: A Practical Guide to Ambulatory Glucose Profile Interpretation
Doupis, J., & Horton, E. S. (2022) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2022.18.1.20 · Cited by 14
“41 44”
Azcoitia, P., Rodríguez-Castellano, R., Saavedra, P., Alberiche-Ruano, M. P., Marrero, D., Wägner, A. M., Ojeda, A., & Boronat, M. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231191544 · Cited by 11
“20 The aim of this work was to detect variables that could better explain the differences between HbA1c and GMI in an ethnically homogeneous cohort of people with type 1 diabetes, both in terms of those glucometric variables that could detect recent glucose fluctuations not captured by HbA1c, and…”
Prinz, N., Konrad, K., Brack, C., Hahn, E., Herbst, A., Icks, A., Grulich‐Henn, J., Jorch, N., Kastendieck, C., Mönkemöller, K., et al. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0898 · Cited by 11
Yoo, J. H., Yang, S. H., Kim, G., & Kim, J. H. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0185 · Cited by 10
“Several studies reported that Black individuals have higher HbA1c level than non-Hispanic White individuals with a given mean glucose level in type 1 diabetes 12,13 and type 2 diabetes.”
Racial Differences in ctDNA Profiles, Targeted Therapy Use, and Outcomes in Metastatic Breast Cancer
Podany, E. L., Foffano, L., Gerratana, L., Medford, A. J., Clifton, K., Tapiavala, S., Velimirovic, M., Lipsyc-Sharf, M. D., Reduzzi, C., Bubie, A., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.61899 · Cited by 10
Joung, H. N., Kwon, H., Baek, K., Song, K., & Kim, M. K. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.35.2.377 · Cited by 10
Knowledge of Hemoglobin A1c and Glycemic Control in an Urban Population
Memon, R., Levitt, D. L., Prado, S. R. S. N. D., Munir, K. M., & Lamos, E. M. (2021) · Cureus · doi:10.7759/cureus.13995 · Cited by 11
“Other socioeconomic factors that pose a barrier to care in certain ethnic groups should be studied in greater detail [18,19].”
BackgroundAn Examination of the Glucose Management Indicator in Young Children with Type 1 Diabetes
Monzon, A. D., Patton, S. R., & Clements, M. A. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211023171 · Cited by 11
Association Between Time in Range and HbA1c in Japanese Patients With Type 2 Diabetes Mellitus
Kurozumi, A., Okada, Y., Mita, T., Wakasugi, S., Katakami, N., Yoshii, H., Kanda, K., Nishida, K., Mine, S., Tanaka, Y., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109836 · Cited by 11
Bergenstal, R. M., Xu, Y., Dunn, T. C., Choudhary, P., & Ajjan, R. (2026) · Diabetologia · doi:10.1007/s00125-026-06739-w · Cited by 9
Self-citationSalam, M., Bailey, R. J., Calhoun, P. M., McGill, J. B., Bergenstal, R. M., Price, D. A., & Beck, R. W. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0387 · Cited by 9
“5,21 However, Selvin et al found a strong correlation between mean glucose and HbA1c for participants with T2D, but no evidence that race affected this relationship.”
Self-citationLinks of positive affect and stress to HbA1c: a prospective longitudinal study
Horner, F. S., Helgeson, V. S., & Korytkowski, M. T. (2023) · Journal of Behavioral Medicine · doi:10.1007/s10865-023-00408-8 · Cited by 10
“While race was not related to PA, we controlled for race because research has shown HbA1c may differ systematically between White and Black persons (Bergenstal et al., 2017).”
What Role Might There Be for Continuous Glucose Monitoring in the Assessment of Diabetes Risk?
Miller, E. M., Polonsky, W. H., & Miller, K. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0136 · Cited by 9
Block, C. E. M. D., CHENG, A. Y. Y., Christensen, T. B., Patted, U. R. H., & Ginovker, A. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01429-x · Cited by 9
“4% higher in African American and Hispanic people than in Caucasian people for the same mean glucose concentration [8].”
BackgroundShah, V. N., Kanapka, L. G., Karakus, K. E., Kollman, C., & Beck, R. W. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241254811 · Cited by 9
Self-citationWolf, R. M., Patel, D., Gera, S., Molano, G. A., Dolivera, T., Meighan, S. S., Brown, E. A., & Marks, B. E. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0612 · Cited by 9
Rationale and Design for a GRADE Substudy of Continuous Glucose Monitoring
Larkin, M., Nathan, D. M., Bebu, I., Krause-Steinrauf, H. J., Herman, W. H., Higgins, J. M., Tiktin, M., Cohen, R. M., Lund, C., Bergenstal, R. M., et al. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0202 · Cited by 9
Self-citationChristakis, N. J., Gioe, M., Gómez, R., Felipe, D. L., Soros, A., McCarter, R., & Chalew, S. A. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231199113 · Cited by 10
“10 A third study in older adults with both type 1 and type 2 diabetes using Abbott FreeStyle Libre Pro CGM reported a higher percentage of non-white patients having HGI GMI ≥ 0.5% compared to white patients.”
InfluentialChaudhry, U. A. R., Carey, I. M., Critchley, J., DeWilde, S., Limb, E. S., Bowen, L., Panahloo, A., Cook, D. G., Whincup, P. H., & Harris, T. J. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.111023 · Cited by 9
Selvin, E., Wang, D., Rooney, M. R., Echouffo-Tcheugui, J. B., Fang, M., Zeger, S. L., Sartini, J., Tang, O., Coresh, J., Aurora, R. N., et al. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0178 · Cited by 9
Bovee, L. B., & Hirsch, I. B. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0028 · Cited by 10
CROMER, S. J., Thaweethai, T., & Wexler, D. J. (2023) · Diabetologia · doi:10.1007/s00125-023-05997-2 · Cited by 8
Aldahlawi, S., Nourah, D., & Andreana, S. (2021) · Current Diabetes Reviews · doi:10.2174/1573399817666210806120300 · Cited by 8
Helgeson, V. S., Naqvi, J. B., Korytkowski, M. T., & Gary‐Webb, T. L. (2021) · Diabetes Care · doi:10.2337/dc21-0734 · Cited by 8
Chalew, S. A., Delamater, A. M., Washington, S., Bhat, J. N., Franz, D. Z., Gómez, R., Felipe, D. L., Tieh, P., & Finger, L. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211021386 · Cited by 8
Glycemic Metrics Derived From Intermittently Scanned Continuous Glucose Monitoring
Hansen, K. W., & Bibby, B. M. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820975822 · Cited by 8
REDONDO, M. J., Libman, I. M., Cheng, P., Kollman, C., Tosur, M., Gal, R. L., Bacha, F. F., KLINGENSMITH, G. J., & Clements, M. A. (2018) · Diabetes Care · doi:10.2337/dci18-0017 · Cited by 8
Self-citationPractical Approaches to Continuous Glucose Monitoring in Primary Care: A UK-Based Consensus Opinion
Fernando, K., Alabraba, V., Welsh, J. B., Seidu, S., Strain, W. D., Bell, H. E., Davies, S., & Evans, M. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01706-x · Cited by 7
“The GMI-HbA1c relationship shows considerable variability between individuals and may also be influenced by race-related factors [30].”
Nishimura, R., Okada, Y., Kuroda, A., Suzuki, J., Hirota, Y., Matsuhisa, M., Ishiguro, M., Ohno, T., Suganuma, Y., Tanaka, K., et al. (2025) · Diabetology International · doi:10.1007/s13340-025-00820-2 · Cited by 9
Pemberton, J. S., Fang, Z., Chalew, S. A., & Uday, S. (2025) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2024-004369 · Cited by 9
“…locations demonstrating a 4–5 mmol/mol higher HbA1c for CYP from Black ethnic background relative to their White counterparts, independent of MBG. 12 15–17 Our study’s key strengths in comparison to other work include our use of 90-day CGM data with an iCGM system (Dexcom G6), while attaining no…”
Influential
Metadata
- Authors
- Bergenstal, R. M., Gal, R. L., Connor, C. G., Gubitosi-Klug, R., Kruger, D., Olson, B. A., Willi, S. M., Aleppo, G., Weinstock, R. S., Wood, J., Rickels, M., DiMeglio, L. A., Bethin, K. E., Marcovina, S., Tassopoulos, A., Lee, S., Massaro, E., Bzdick, S., Ichihara, B., Markmann, E., McGuigan, P., Woerner, S., Ecker, M., Beck, R. W., & for the T1D Exchange Racial Differences Study Group*
- Affiliations
- Children's Hospital of Philadelphia (US)
- From International Diabetes Center Park Nicollet, Minneapolis, Minnesota; Jaeb Center for Health Research, Tampa, Florida; University Hospitals of Cleveland, Cleveland, Ohio; Henry Ford Health System, Detroit, Michigan; Children's Hospital of Philadelphia and Perelman School of Medicine and Rodebaugh Diabetes Center, University of Pennsylvania, Philadelphia, Pennsylvania; Northwestern University, Chicago, Illinois; SUNY Upstate Medical University, Syracuse, New York;
- ORCID
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2017-07-18
- Volume
- 167
- Issue
- 2
- Pages
- 95-102
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2625092562
- Semantic Scholar
- f0f7e81895f364d37c2c4682799f26717d554b9e
- Cited by
- 306
- References
- 40
- Citations by year
- 2026: 16 · 2025: 30 · 2024: 32 · 2023: 29 · 2022: 39 · 2021: 40 · 2020: 41 · 2019: 31 · 2018: 37 · 2017: 11
- FWCI
- 25.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Leona M. and Harry B. Helmsley Charitable Trust
- Abbott Diabetes Care
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Keywords
- HbA1c, racial differences, type 1 diabetes, glycemic control, hemoglobin glycation, glycated albumin, fructosamine, Black patients, continuous glucose monitoring
- MeSH terms
- Glycated Serum Albumin, Adolescent, Adult, Black or African American, Blood Glucose, Child, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Male, Middle Aged, Prospective Studies, Serum Albumin, United States, Blood Glucose Self-Monitoring, Glycation End Products, Advanced, Fructosamine, Black People, White People, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.